SciClone Pharmaceuticals
16 clinical trials · Sponsor
◉ Watch SciClone Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer (NCT07076680) | SciClone Pharmaceuticals | 2025-08-01 |
| Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer (NCT06548919) | SciClone Pharmaceuticals | 2024-08-08 |
| Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC (NCT06544577) | SciClone Pharmaceuticals | 2024-07-13 |
| Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. (NCT06047535) | SciClone Pharmaceuticals | 2023-10-31 |
| PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors (NCT05357196) | SciClone Pharmaceuticals | 2020-04-13 |
| An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma (NCT03439761) | SciClone Pharmaceuticals | 2018-03-07 |
Track SciClone Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.